Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
作者信息
Enos Tyler, Jeong Haneol S, Vandergriff Travis, Jacobe Heidi T, Chong Benjamin F
机构信息
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
出版信息
Dermatol Ther. 2020 Nov;33(6):e13834. doi: 10.1111/dth.13834. Epub 2020 Jul 8.
Abstract
摘要
相似文献
1
Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
Dermatol Ther. 2020 Nov;33(6):e13834. doi: 10.1111/dth.13834. Epub 2020 Jul 8.
2
Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
J Dermatol. 2020 Feb;47(2):e53-e54. doi: 10.1111/1346-8138.15185. Epub 2019 Dec 15.
3
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Dermatol Ther. 2020 Jul;33(4):e13565. doi: 10.1111/dth.13565. Epub 2020 May 26.
4
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
J Med Case Rep. 2020 Nov 3;14(1):210. doi: 10.1186/s13256-020-02504-8.
5
Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
Dermatol Ther. 2018 Sep;31(5):e12660. doi: 10.1111/dth.12660. Epub 2018 Aug 28.
6
Acute generalized exanthematous pustulosis due to terbinafine.
Dermatol Ther. 2018 Jul;31(4):e12617. doi: 10.1111/dth.12617. Epub 2018 May 21.
7
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
Am J Dermatopathol. 2021 May 1;43(5):342-348. doi: 10.1097/DAD.0000000000001819.
8
Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e457-e459. doi: 10.1111/jdv.16613. Epub 2020 Jul 3.
9
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.
An Bras Dermatol. 2017 May-Jun;92(3):404-406. doi: 10.1590/abd1806-4841.20175561.
10
Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2777-2779.e1. doi: 10.1016/j.jaip.2020.05.046. Epub 2020 Jun 7.
引用本文的文献
1
Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management.
Am J Clin Dermatol. 2023 Jul;24(4):557-575. doi: 10.1007/s40257-023-00779-3. Epub 2023 May 8.
2
Clinical features of acute generalized exanthematous pustulosis caused by hydroxychloroquine in rheumatology patients and exploration of gene mutations.
Front Med (Lausanne). 2023 Apr 6;10:1161837. doi: 10.3389/fmed.2023.1161837. eCollection 2023.
3
COVID-19 infection leading to acute pustular dermatoses.
Arch Dermatol Res. 2023 May;315(4):685-697. doi: 10.1007/s00403-022-02450-z. Epub 2022 Nov 1.
4
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.
Pharmaceuticals (Basel). 2022 May 21;15(5):634. doi: 10.3390/ph15050634.
5
Acute generalized exanthematous pustulosis due to hydroxichloroquine.
Dermatol Ther. 2022 Jul;35(7):e15520. doi: 10.1111/dth.15520. Epub 2022 Apr 23.
6
Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.
J Clin Med. 2022 Jan 13;11(2):397. doi: 10.3390/jcm11020397.
7
Severe and life-threatening COVID-19-related mucocutaneous eruptions: A systematic review.
Int J Clin Pract. 2021 Dec;75(12):e14720. doi: 10.1111/ijcp.14720. Epub 2021 Sep 28.
8
A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
Dermatol Ther. 2021 Jan;34(1):e14662. doi: 10.1111/dth.14662. Epub 2020 Dec 26.
本文引用的文献
1
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.
JAMA Netw Open. 2020 Apr 24;3(4):e209035. doi: 10.1001/jamanetworkopen.2020.9035.
2
Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review.
J Am Acad Dermatol. 2020 Aug;83(2):563-578. doi: 10.1016/j.jaad.2020.04.024. Epub 2020 Apr 11.
3
A case of prolonged generalized exanthematous pustulosis caused by hydroxychloroquine-Literature review.
Clin Case Rep. 2018 Oct 26;6(12):2391-2395. doi: 10.1002/ccr3.1811. eCollection 2018 Dec.
4
Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
Dermatol Ther. 2018 Sep;31(5):e12660. doi: 10.1111/dth.12660. Epub 2018 Aug 28.
5
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.
An Bras Dermatol. 2017 May-Jun;92(3):404-406. doi: 10.1590/abd1806-4841.20175561.
6
7
Acute generalized exanthematous pustulosis (AGEP): A review and update.
J Am Acad Dermatol. 2015 Nov;73(5):843-8. doi: 10.1016/j.jaad.2015.07.017. Epub 2015 Sep 6.
8
Rapid clearing of acute generalized exanthematous pustulosis after administration of ciclosporin.
Clin Exp Dermatol. 2009 Dec;34(8):e757-9. doi: 10.1111/j.1365-2230.2009.03480.x. Epub 2009 Jul 29.
9
Acute generalized exanthematous pustulosis precipitated by hydroxychloroquine.
J Am Acad Dermatol. 2004 Apr;50(4):650-1. doi: 10.1016/s0190-9622(03)02733-6.
Zotero 插件